Loading the section…
The price of Sonoma Pharmaceuticals, Inc. (SNOA) on October 9, 2026 is 1.23 USD, +6.03% on the day. Over 52 weeks the stock traded between 0.8500 USD and 4.44 USD; the price now sits 11% of the way up that range. Over the past year the price changed by −70.50%. Market capitalization is 2.21 million USD, rank 95 among 99 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −69.78 %
Sonoma Pharmaceuticals, Inc. trades on Nasdaq under the ticker SNOA. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks SNOA has traded between 0.8500 $ and 4.44 $. As of 9 October 2026 the price stood 10.58 % of the way from the 52-week low to the high.
Over one year SNOA shares fell 70.50 %; over six months they fell 46.05 %. Volatility over 90 days is 54.64 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss for the latest fiscal year, so a price-to-earnings ratio is not calculated. Price to sales is 0.1, below the sector median of 4.0. Price to book is 0.7, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 1.17 | 1.26 | 1.16 | 1.23 | 49,300 |
| 8 October 2026 | 1.20 | 1.20 | 1.14 | 1.16 | 89,000 |
| 7 October 2026 | 1.23 | 1.23 | 1.20 | 1.22 | 31,600 |
| 6 October 2026 | 1.27 | 1.27 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301, US
Sonoma Pharmaceuticals, Inc. reported revenue of 20M $ and a net loss of 3M $ for the latest fiscal year. Net margin is −16.26 %. Revenue changed by +36.68 % year over year. Earnings per share are −1.89 $. Market capitalisation is 2M $.
SNOA has a return on equity of −102.58 %, below the sector median of −41.68 %. Return on assets is −22.74 %, above the sector median of −32.11 %. Operating margin is −12.60 %, above the sector median of −26.84 %.
| 328M |
| DXCMDexCom, Inc. | 84.11 | −0.36 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.05 | +1.46 % | 271M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 1.21 |
| 1.23 |
| 44,700 |
| 5 October 2026 | 1.24 | 1.25 | 1.22 | 1.22 | 18,600 |
| 2 October 2026 | 1.28 | 1.29 | 1.22 | 1.24 | 27,400 |
| 1 October 2026 | 1.31 | 1.31 | 1.25 | 1.25 | 35,300 |
| 30 September 2026 | 1.24 | 1.30 | 1.20 | 1.28 | 110,700 |
| 29 September 2026 | 1.27 | 1.28 | 1.24 | 1.25 | 7,600 |
| 28 September 2026 | 1.29 | 1.29 | 1.24 | 1.26 | 30,400 |
| 25 September 2026 | 1.24 | 1.29 | 1.24 | 1.27 | 24,300 |
| 24 September 2026 | 1.24 | 1.29 | 1.20 | 1.25 | 77,700 |
| 23 September 2026 | 1.31 | 1.31 | 1.25 | 1.25 | 41,500 |
| 22 September 2026 | 1.27 | 1.30 | 1.26 | 1.30 | 14,400 |
| 21 September 2026 | 1.28 | 1.28 | 1.25 | 1.25 | 27,600 |
| 18 September 2026 | 1.26 | 1.34 | 1.24 | 1.28 | 147,400 |
| 17 September 2026 | 1.24 | 1.27 | 1.24 | 1.26 | 7,700 |
| 16 September 2026 | 1.28 | 1.28 | 1.23 | 1.23 | 106,100 |
| 15 September 2026 | 1.30 | 1.30 | 1.27 | 1.28 | 71,100 |
| 14 September 2026 | 1.30 | 1.30 | 1.28 | 1.29 | 22,100 |